Abstract
We evaluated our present treatment of hypertension and sought a way to improve it. We studied 164 of outpatients we treated in 2002. Mean systolic blood pressure (SBP)±SD was 142.0±11.3, and 56% of patients had SBP over 140 mmHg. We used more diuretics in patients with good control of SBP (19% vs. 7% of patients; p=0.012). After observing our hypertensive patients, we changed our treatment in a goal-oriented manner. Our goal was blood pressure below 140/90 mmHg. We used, in principle, additional small amounts of diuretics for inadequately treated patients. We followed 147 of the 164 patients from 2002 to 2006. During this period, mean SBP decreased to 134.7±9.1 mmHg (p<0.001), and the frequency of patients with SBP >140 mmHg decreased to 14% (p<0.001). We used more diuretics in 2006 than in 2002 (12% to 46% p<0.001). To estimate the risks and benefits of diuretics, in 2006 we analyzed 510 patients who had been followed for at least 2 years. Potassium supplementation was needed in 28% of diuretic-treated patients and 7% of patients without diuretics. We found a correlation between the use of diuretics and good SBP control in the entire patient group as well as in patients with diabetes. In the control of diabetes mellitus, we found no statistical difference between patients treated with diuretics and those not. We found diuretics had no adverse effects with respect to new-onset diabetes mellitus.
Similar content being viewed by others
Article PDF
References
ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group: Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002; 288: 2981–2997.
Julius S, Kjeldsen SE, Weber M, et al: Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. Lancet 2004; 363: 2022–2031.
Davis BR, Piller LB, Cutler JA, et al, Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group: Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Circulation 2006; 113: 2201–2210.
Kostis JB, Wilson AC, Freudenberger RS, Cosgrove NM, Pressel SL, Davis BR, SHEP Collaborative Research Group: Long-term effect of diuretic-based therapy on fatal outcomes in subjects with isolated systolic hypertension with and without diabetes. Am J Cardiol 2005; 95: 29–35.
Savage PJ, Pressel SL, Curb JD, et al, SHEP Cooperative Research Group: Influence of long-term, low-dose, diuretic-based, antihypertensive therapy on glucose, lipid, uric acid, and potassium levels in older men and women with isolated systolic hypertension: the Systolic Hypertension in the Elderly Program. Arch Intern Med 1998; 158: 741–751.
PROGRESS Collaborative Group: Randomised trial of a perindopril-based blood-pressure–lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 2001; 358: 1033–1041.
Weinehall L, Ohgren B, Persson M, et al: The ‘rule of halves’ still exists. J Hypertens 2002; 20: 2081–2088.
Lang T, de Gaudemaris R, Chatellier G, Hamici L, Diene E, Epidemiology Group of the Societe Francaise d'Hypertension Arterielle and the IHPAF Working Physicians Group: Prevalence and therapeutic control of hypertension in 30,000 subjects in the workplace. Hypertension 2001; 38: 449–454.
Alam MG, Barri YM : Systolic blood pressure is the main etiology for poorly controlled hypertension. Am J Hypertens 2003; 16: 140–143.
Ono A, Fujita T : Factors relating to inadequate control of blood pressure in hypertensive outpatients. Hypertens Res 2003; 26: 219–224.
Saito I, Kawabe H, Tsujioka M, Hirose H, Shibata H : Trends in pharmacologic management of hypertension in Japan one year after the publication of the JSH 2000 guidelines. Hypertens Res 2002; 25: 175–178.
Mori H, Ukai H, Yamamoto H, et al: Current status of antihypertensive prescription and associated blood pressure control in Japan. Hypertens Res 2006; 29: 143–151.
Amar J, Chamontin B, Genes N, Cantet C, Salvador M : Why is hypertension so frequently uncontrolled in secondary prevention. J Hypertens 2003; 21: 1199–1205.
Alderman MH, Cohen H, Madhavan S : Diabetes and cardiovascular events in hypertensive patients. Hypertension 1999; 33: 1130–1134.
Zillich AJ, Garg J, Basu S, Bakris GL, Carter BL : Thiazide diuretics, potassium, and the development of diabetes: a quantitative review. Hypertension 2006; 48: 198–200.
Mason JM, Dickinson HO, Nicolson DJ, Campbell F, Ford GA, Williams B : The diabetogenic potential of thiazide-type diuretic and beta-blocker combinations in patients with hypertension. J Hypertens 2005; 23: 1777–1781.
Glynn RJ, L'Italien GJ, Sesso HD, Jackson EA, Buring JE : Development of predictive models for long-term cardiovascular risk associated with systolic and diastolic blood pressure. Hypertension 2002; 39: 105–110.
Haider AW, Larson MG, Franklin SS, Levy D : Systolic blood pressure, diastolic blood pressure, and pulse pressure as predictors of risk for congestive heart failure in the Framingham Heart Study. Ann Intern Med 2003; 138: 10–16.
Singer G, Izhar M, Black H : Goal-oriented hypertension management: translating clinical trials to practice. Hypertension 2002; 40: 464–469.
Inaba M, Noguchi Y, Yamamoto T, et al: Effects of a low dose of indapamide, a diuretic, given daily or every-other-day on blood pressure and metabolic parameters. Hypertens Res 2004; 27: 141–145.
Plavinik FL, Rodrigues CI, Zanella MT, Ribeiro AB : Hypokalemia, glucose intolerance, and hyperinsulinemia during diuretic therapy. Hypertension 1992; 19 ( 2 Suppl): II26–II29.
Curb JD, Pressel SL, Cutler JA, et al: Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group. JAMA 1996; 276: 1886–1892.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kudoh, T., Nagawaga, T. & Nakagawa, I. Additional Small Amounts of Diuretics Improve Blood Pressure Control at Low Cost without Disadvantages in Blood Sugar Metabolism. Hypertens Res 31, 455–462 (2008). https://doi.org/10.1291/hypres.31.455
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1291/hypres.31.455
Keywords
This article is cited by
-
Benefits and pitfalls of cardiovascular medication in seniors
Wiener klinische Wochenschrift (2013)
-
The relationship between antihypertensive combination therapies comprising diuretics and/or β-blockers and the risk of new-onset diabetes: a retrospective longitudinal cohort study
Hypertension Research (2009)